Tiziana Life Sciences PLC Recorded Big Gain

Tiziana Life Sciences PLC (TLSA:NASDAQ) shot up at $0.69, representing a gain of 24.8%. The stock got featured on our News Catalysts scanner on Fri, Sep 16, 2022 at 07:47 AM in the 'ACQUISITION' category. From Tue, Sep 06, 2022, the stock recorded 77.78% Up Days and 50.00% Green Days

About Tiziana Life Sciences PLC (TLSA:NASDAQ)

Tiziana Life Sciences PLC is involved in the business of developing novel therapeutics for cancer with a focus on late-stage growth and complementary diagnostic tools, with the capability of predicting disease aggressiveness and prognosis in breast cancer patients. The group also has interests, beyond pure oncology, in the discovery and development of monoclonal antibody-based biologics used to benefit patients with inflammatory and auto-immune disorders. The company has a single reporting segment, The Research, and Development of Biotechnological and Pharmaceutical Products. Its lead compound, milciclib (TZLS-201), is a molecule which blocks the action of specific enzymes involved in cell division as well as a number of other protein kinases.